Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.
Journal: Blood cancer journal
Published: July 20, 2020
Use of daratumumab in high risk multiple myeloma: A meta-analysis.
Journal: EJHaem
Published: May 28, 2020
Modern Treatments and Future Directions for Relapsed/Refractory Multiple Myeloma Patients.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 25, 2020
Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End?
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 01, 2019
Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells.
Journal: Thrombosis and haemostasis
Published: May 13, 2016
Showing 1-5 of 5
Last Updated: 09/26/2026